Is OncoTRACE by OncoDNA the right test right for you
This test is about helping you and your clinician determine the effect your drugs or other therapies are having on your cancer – it is completely personalised to you.
It compares the unique molecular structure of your tumour before and after a period of treatment – so you will need to have had a previous analysis, either OncoSTRAT&GO or any previous sequencing results with a minimum of genes (+/- 100).
Ask your clinician how you can get this test.
- Why?►Close tab
Monitoring the effect of your treatment
OncoTRACE by OncoDNA is used to monitor the progression of your tumour and to detect response – or perhaps more importantly, lack of response or resistance – to treatment as soon as it appears. This test is customised for you, as it contains personal cancer-specific markers and variants identified in your previous genomic analysis. It therefore enables your clinician to make informed decisions about possible alternative therapies and give you a truly personalised treatment plan.
You can discuss this with your clinician, or if you would like to talk to one of our experts about this test, call us on +44 (0) 1270 623 179
- How?►Close tab
What do I need to do?
This test requires two blood samples taken after a period of treatment to compare with a sample of blood or tumour taken at an earlier stage. Your clinician will advise on whether a sample is available or if a new blood test is required.
- Process►Close tab
Through your clinician
This test is only available through your clinician, who will receive your test results directly.
Step 1: Buy the test
You will receive an email asking you to confirm that you have authorised Everything Genetic Ltd to be given a sample of your blood.
We will contact your pathologist directly and organise the collection of your samples and delivery to the lab.
Step 3: Reporting
Your samples will be analysed and a report will be generated. Starting from OncoSTRAT&GO results, as well as any other sequencing dataset generated by other sequencing services, the report should be sent within seven working days once OncoDNA has received and quality checked the liquid biopsy sample and all the required clinical information. Starting from sequencing data provided by another platform, please count 10 additional working days for primers synthesis.
Step 4: Results
We analyse the dynamic evolution of your personal variants and report any new variants associated with resistance and/or new treatment options. Your clinician will receive a comprehensive report covering all of these elements together with details of specific therapies and clinical trials relevant to you.
- Clinicians►Close tab
Onco DNA Tests information for Clinicians
OncoDNA’s innovative approach is to combine next-generation sequencing (NGS) with immunohistochemistry (IHC). This gives a comprehensive view of a tumour profile, at both DNA and protein levels and opens more therapeutic options for your patient.
In 2016, liquid biopsy analyses were added to its solution portfolio, either in combination with solid biopsy analysis or as a stand-alone analysis for diagnostic or monitoring purposes.
Compare our four solutions to see which is right for your patient:
OncoDEEP – cost-effective solution combining DNA and protein analysis of a solid tumour sample
OncoSTRAT&GO – complete solution integrating the analyses of solid and liquid biopsies
OncoSELECT – cancer-specific solution from a liquid biopsy sample
OncoTRACE – truly personalised monitoring solution from liquid biopsy sample
This test is provided by:
Frequently asked questions
- Do I need a doctor to authorise this test?
- Yes, your doctor will need to provide the sample required for this test
- Will my health insurance cover the cost of this test?
- Many health insurance plans cover the cost of genetic testing – check with your provider to find out if it is in your policy.
- How soon do I get my results?
- Usually within seven working days, although it may be longer depending on where the comparison information is being sourced